Insider Buying: OneMedNet (NASDAQ:ONMD) Insider Acquires $89,999.91 in Stock

OneMedNet Corporation (NASDAQ:ONMDGet Free Report) insider Jeffrey Yu bought 142,857 shares of the firm’s stock in a transaction on Thursday, September 10th. The stock was purchased at an average price of $0.63 per share, with a total value of $89,999.91. Following the completion of the acquisition, the insider owned 8,923,267 shares of the company’s stock, valued at approximately $5,621,658.21. This trade represents a 1.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Jeffrey Yu also recently made the following trade(s):

  • On Tuesday, June 23rd, Jeffrey Yu bought 158,730 shares of OneMedNet stock. The stock was purchased at an average cost of $0.63 per share, for a total transaction of $99,999.90.
  • On Tuesday, June 16th, Jeffrey Yu purchased 172,414 shares of OneMedNet stock. The shares were purchased at an average price of $0.58 per share, for a total transaction of $100,000.12.

OneMedNet Price Performance

ONMD stock opened at $0.62 on Thursday. The firm has a market capitalization of $36.49 million, a P/E ratio of -3.85 and a beta of 1.12. OneMedNet Corporation has a 52-week low of $0.49 and a 52-week high of $4.22. The company’s 50 day simple moving average is $0.66 and its 200-day simple moving average is $0.75.

OneMedNet (NASDAQ:ONMDGet Free Report) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.04) EPS for the quarter. The company had revenue of $0.29 million for the quarter.

Wall Street Analysts Forecast Growth

ONMD has been the topic of a number of research analyst reports. Wall Street Zen downgraded OneMedNet from a “hold” rating to a “sell” rating in a report on Saturday, May 23rd. Weiss Ratings raised OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 24th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company currently has an average rating of “Sell”.

Read Our Latest Stock Report on ONMD

OneMedNet Company Profile

(Get Free Report)

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

Further Reading

Insider Buying and Selling by Quarter for OneMedNet (NASDAQ:ONMD)

Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.